There is no evidence demonstrates the role of hyperglycemia on the expression of glycosylated ACE2 and/or on the non-enzymatic glycation of ACE2, which could impact its expression in the cell surface and its binding to SARS-CoV-2 spike protein (15). The gene discussed is ACE2; the disease is Hyperglycemia.